Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research Units
Researchers
Grants & Contracts
Research output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
MT-3921: A Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of MT-3921 in Subjects with Acute Traumatic Cervical Spinal Cord Injury
Motiei-Langroudi, Rouzbeh
(PI)
Neurosurgery
Overview
Grants and Contracts Details
Status
Active
Effective start/end date
6/30/21
→
7/10/23
Funding
Mitsubishi Tanabe Pharma Development America Incorporated:
$8,750.00
View all
View less